
- Telehealth Visits
- Insurance plan information

Rhonald (Ron) Abitona, NP
He | Him | HisInterventional Pulmonology- Telehealth Visits
- Insurance plan information



Rhonald (Ron) Abitona, NP
He | Him | HisInterventional Pulmonology- Telehealth Visits
- Insurance plan information
On this page
About me
Rhonald Abitona, who goes by Ron, is a nurse practitioner who cares for patients with conditions of the airways and lungs. He works with pulmonologists using minimally invasive procedures to diagnose and treat lung cancer, pleural diseases (those affecting the tissues lining the chest cavity and covering the lungs), and other airway or lung disorders.
Prior to joining the interventional pulmonary practice, Abitona worked in cardiothoracic surgery and critical care at UCSF. He has also worked as an intensive care unit nurse at Zuckerberg San Francisco General Hospital and Trauma Center.
After earning a bachelor's degree in exercise biology at the University of California, Davis, Abitona earned his master's degree in nursing at the University of San Francisco. He later completed UCSF's post-master's program in adult-gerontology acute care.
Abitona is a member of the American Association of Nurse Practitioners and American Association for Bronchology and Interventional Pulmonology.
Abitona is a traveler, foodie and dog lover.
Education & training
Board certification
- Adult-Gerontology Acute Care NP, American Nurses Credentialing Center
Degree
- MSN, University of San Francisco
My expertise
Specialties
Clinical Trials query: q=health_gateway_id_ss%3A%28%223241%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%223241%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.